Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel vaccine approaches

H C Ertl1, Z Xiang

  • 1Wistar Institute, Philadelphia, PA 19104, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|May 15, 1996
PubMed
Summary
This summary is machine-generated.

New subunit vaccines using recombinant viruses, peptides, or DNA show promise for infectious diseases and cancer immunotherapy. While not yet for mass use, these advanced vaccine technologies are advancing through clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

Rechallenge With Immune Checkpoint Inhibitors in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

TGF-β controls developmental fate and functional identity of thymic γδ T cells.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Distinguishing Th17 cells as a unique subset.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Subunit vaccines utilize advances in immunology, molecular biology, and peptide biochemistry.
  • Approaches include viral/bacterial recombinants, peptides, and plasmid vectors.
  • Several novel vaccine strategies are currently in clinical trials.

Purpose of the Study:

  • To review recent advances in subunit vaccine development.
  • To assess the potential efficacy of various vaccine constructs for infectious diseases and cancer immunotherapy.
  • To highlight the advantages and limitations of different vaccine platforms.

Main Methods:

  • Review of current research on recombinant viral vaccines (vaccinia, adenovirus).
  • Evaluation of peptide-based vaccines for therapeutic applications.

Related Experiment Videos

  • Assessment of genetic vaccines (plasmid vectors) and their progression in clinical trials.

    • Main Results:

    • Recombinant viral vaccines, particularly adenovirus-based, show potent immune responses and potential for mucosal immunity.
    • Vaccinia virus recombinants are heat-stable and suitable for oral administration in wildlife immunization.
    • Peptide vaccines may offer tailored cancer therapies, while genetic vaccines are progressing rapidly in human trials.

    Conclusions:

    • No single subunit vaccine approach is universally effective for all applications.
    • Recombinant adenoviruses offer safety and efficacy advantages for certain infectious agents.
    • Genetic and peptide vaccines hold significant potential for future infectious disease prevention and cancer immunotherapy, pending safety confirmation.